Prostate Specific Antigen (PSA)
Biomarker Market
Prostate Specific Antigen (PSA) Biomarker Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Prostate Specific Antigen (PSA) Biomarker Market Size and Growth
The Prostate Specific Antigen (PSA) Biomarker market research reports indicate a growing demand due to increasing prevalence of prostate cancer. The market size is estimated to reach $1.2 billion by 2026, driven by advancements in diagnostic technologies and the rising awareness about the importance of early detection in improving patient outcomes.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Siemens Healthcare
◍ DiaSorin
◍ Roche
◍ Tosoh Bioscience
◍ Fujirebio
◍ BodiTech
◍ GE Healthcare
◍ Endocare
◍ Quest Diagnostics
◍ Bio-Rad Laboratories
◍ QIAGEN
◍ Myriad RBM
The Prostate Specific Antigen (PSA) Biomarker Market is highly competitive with key players like Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, and others. These companies offer PSA testing products and diagnostic services to help in the early detection of prostate cancer and monitor disease progression.
- Abbott: $35.19 billion (2019)
- Roche: $61.5 billion (2019)
- Siemens Healthcare: €13.97 billion (2019)
Request Sample Report
Market Segmentation
By Application
Diagnostics
Drug Discovery
Personalized Medicine
Others
Request Sample Report
By Product
Blood
Semen
Urine
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients